Physician profile
Amy Hollen
NPI 1750463816
$6,804.43
in general payments reported to CMS, 2019-2025
48 companies · $1,352 in 2025
The $1,352 reported for 2025 was more than what 91% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $390 · 2020: $466 · 2021: $960 · 2022: $1,051 · 2023: $1,241 · 2024: $1,344 · 2025: $1,352.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,837 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,837.39 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,164.75 | 2021-2025 | |
| Astrazeneca Pharmaceuticals Lp | $1,033.31 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Novo Nordisk INC | $841.74 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $371.52 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Glaxosmithkline, LLC. | $347.88 | 2020-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Pfizer INC. | $287.44 | 2019-2025 | |
| Teva Pharmaceuticals USA, INC. | $277.52 | 2019-2025 | Ajovy, Austedo Xr, Austedo Xr |
| Astellas Pharma US INC | $252.06 | 2020-2025 | Veozah |
| Amgen INC. | $175.41 | 2019-2025 | Evenity, Prolia |
| Dexcom, INC. | $158.52 | 2021-2025 | Dexcom G6 Transmitter |
| Janssen Pharmaceuticals, INC | $157.36 | 2019-2025 | Spravato |
| Novartis Pharmaceuticals Corporation | $147.32 | 2022-2025 | |
| Supernus Pharmaceuticals, INC. | $110.64 | 2020-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $104.79 | 2020-2023 | Trintellix |
| Bayer Healthcare Pharmaceuticals INC. | $94.20 | 2022-2025 |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Hollen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.